Skip to main content
. 2014 Dec 15;5(1):243–254.

Figure 3.

Figure 3

Suppression of C6 glioma growth in rats by ADS-I wafer implants. C6 glioma-bearing rats were received blank wafer implants (control group), 0.77 mg-ADS-I wafer implants, 1.53 mg-ADS-I wafer implants, or 153 µL of ADS-I solution (containing 1.53 mg ADS-I). After 14 days of treatment, the tumor growth in the rats was measured using MRI imaging analysis. A. A representative imaging of MRI analysis of C6 glioma growth in intracerebral before (day 0) and after 14 days of treatment (day 14). Arrow indicated the tumor tissue. B. The measurements of tumor sizes in each group before (day 0) and after 14 days of treatment. Data are represented as mean ± SD of twelve determinants, and statistically compared by ANOVA (p < 0.0001, blank vs. ADS-I; p < 0.0001, 1.53 mg-ADS-I wafer vs. 1.53 mg-ADS-I solution).